Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer

FRANKFURT, Germany, Nov. 26, 2024 /PRNewswire/ — Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group (“Zentiva”), announced today that it has secured approx. 83.57% of the share capital and approx. 85.27% of voting rights in the context of its voluntary public purchase offer […] L'articolo Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer proviene da La Ragione.

CONTINUA A LEGGERE